The story of Viagra offers a intriguing case study for drug backers . Initially a phenomenal success, generating billions in revenue , the exclusivity end has opened the challenges of relying on a single https://jasonpyve056736.articlesblogger.com/63958101/viagra-and-pharma-a-risky-investment